Role of Apo-lipoprotein A1 as cardiac biomarker for severity of coronary atherosclerosis
Journal of Contemporary Medical Sciences. 2016; 1 (4): 27-30
in English
| IMEMR
| ID: emr-176291
ABSTRACT
Objective:
Coronary heart disease [CAD] is the most prevalent chronic disease and the main leading cause of death in the world, with more than half a million newly diagnosed CAD patients each year. The development of atherosclerosis involves the interaction of multiple metabolic and cellular processes. Central to this are disorders of lipoprotein metabolism. Apolipoprotein A-I is the major protein component of high-density lipoprotein [HDL] in plasma. Chylomicrons secreted from the intestinal enterocyte also contain Apo A-I, but it is quickly transferred to HDL in the blood stream. The aim of this study is to determine if Apo-A1 can be used as indicator to severity and extent of CAD
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Biomarkers
/
Apolipoprotein A-I
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
English
Journal:
J. Contemp. Med. Sci.
Year:
2016
Similar
MEDLINE
...
LILACS
LIS